Glenmark Pharmaceuticals informs about details of KMP
Pursuant to Regulation 30 (5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Glenmark Pharmaceuticals has informed that it enclosed details of Key Managerial Personnel (KMP) of the Company who are severally authorised for determining materiality of an event or information and for the purpose of making disclosures to stock exchange(s) under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.
